An experimental pill to treat Covid developed by the US company Pfizer cuts the risk of hospitalisation or death by 89% in vulnerable adults, clinical trial results suggest.
The drug – Paxlovid – is intended for use soon after symptoms develop in people at high risk of severe disease.
Pfizer says it stopped trials early as the initial results were so positive.
It comes the day after the UK medicines regulator approved a similar treatment from Merck Sharp and Dohme (MSD).
Please subscribe HERE http://bit.ly/1rbfUog
#Covid #BBCNews
Subscribe to our channel here: https://bbc.in/bbcnews For the latest news download the BBC News app or visit BBC.com/news #BBCNews
L'edizione della notte del Tg diretto da Enrico Mentana
L'informazione della testata giornalistica di LA7 diretta da Enrico Mentana
It's been more than 50 years. Now Nasa is about to return to the Moon. Four astronauts – Reid Wiseman,…
In Italia il credito continua a costare caro anche all’inizio del 2026. Secondo Unimpresa, le aziende pagano tassi tra il…